Summary

Other Scenarios:

Buyer: Watson Pharmaceuticals, Inc. (WPI) Last Price: 26.63 Market Cap.: 2.97B
Target: Neurocrine Biosciences, Inc. (NBIX) Last Price: 52.74 Market Cap.: 1.99B

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
*Healthcare 861
Biopharmaceuticals 315
Medical Devices   247
Nutritional Health   23
Outsourced Services   69

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 227)
  • Hydroxyzine HCl
  • Hydroxyzine Pamoate
  • Promethazine
  • Aller-Chlor (Chlorpheniramine)
Target (Total: 21)
  • Urocortin 2
  • CRF R1 Antagonist
  • NBI-6024 (Altered Peptide Ligand)
  • NBI-5788 (Altered Peptide Ligand)
Buyer
  • Watson Laboratories, Inc.
  • Eye Irrigating Solution
  • Nature's Tears
  • Watson Pharmaceuticals, Inc.
Target

n/a

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 3)
  • West Pharmaceutical Services Inc. (WST)
  • Ventiv Health, Inc. (VTIV)
  • Genelabs Technologies (GNLB)
Target (Total: 2)
  • Pfizer Inc. (PFE)
  • Open Text Corporation (USA) (OTEX)
Buyer (Total: 5)
  • McKesson Corporation (MCK)
  • AmerisourceBergen Corp. (ABC)
  • Walgreen Company (WAG)
  • Cardinal Health, Inc. (CAH)
Target (Total: 5)
  • Pfizer Inc. (PFE)
  • GlaxoSmithKline plc (ADR) (GSK)
  • Wyeth (WYE)
  • Eli Lilly & Co. (LLY)

Key Financial Summary:

Metric Buyer Target
Number of Employees 3,844 564
Revenue Per Employee 425,366.4 139,496.5
Total Revenue 407.2 19.5
Total Expenses 372.4 47.1
Other Revenue 0.0 8.2
Cost of Revenue 234.8 0.0
SG&A Expense 66.8 19.3
Research & Development 29.8 27.7
Other Operating Expense 0.0 0.0
Operating Income 34.8 -27.6
Unusual Income 0.0 0.0
Gross Margin % 42.35 100
Metric Buyer Target
Operating Margin % 8.54 -141.68
Total Assets 3,157.4 477.4
Return on Equity % 4.82 -27.6
Cash+ ST Inv. Per Share 6.25 7.08
Total Debt 603.9 57.9
Curr Portion of LTD/Cap Lease 29.9 5.5
Total Debt to Equity 28.22 15.1
LT Debt to Capital 21.15 12.01
Fwd P/E 21.43 76.40
Fwd P/Rev 1.64 9.57
Book Value 2,139.8 383.8

Individual Company Summary

Focused

Buyer

Focused (): *Healthcare > Biopharmaceuticals

Target

Focused (): *Healthcare > Biopharmaceuticals > Neurology

Business Description

Buyer

Watson Pharmaceuticals, Inc. (Watson) is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent (generic) pharmaceutical products. Watson operates manufacturing, distribution, research and development, and administrative facilities primarily in the United States. As of December 31, 2005, the Company marketed more than 125 generic pharmaceutical products and more than 20 brand pharmaceutical products. The Company operates in two segments: generic and brand.

Target

Neurocrine Biosciences, Inc. discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. The Company's product candidates address pharmaceutical markets in the world, including insomnia, anxiety, depression, various female and male health disorders, multiple sclerosis, diabetes and other neurological and endocrine related diseases and disorders. The Company has nine programs in various stages of research and development, including seven programs in clinical development. While the Company independently develops many of its product candidates, it has entered into collaborations for three of its programs. The Company's lead clinical development program, indiplon, is a drug for the treatment of insomnia. It has submitted two New Drug Applications (NDAs) to the United States Food and Drug Administration (FDA) with respect to indiplon.

Product Summary

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
  
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
  
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
  
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes therapeutics that treat female genital disorders, pregnancy, and childbirth.
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
Ophthalmology
The Ophthalmology Subsector includes therapeutics that treat eye disorders, infections, inflammations and irritations.
  
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
Weight Management
The Weight Management Subsectors includes herapeutics that treat and manage weight disorders.
Wound Management
The Wound Management Subsector includes therapeutics that treat cuts, abrasions, and burns from trauma or diseases.
  
Medical Devices  
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
  
Ophthalmology
The Ophthalmology Subsector includes medical devices that diagnose and treat eye disorders.
  
Nutritional Health  
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
  
Outsourced Services  
Analytical Services
The Analytical Services Subsector includes outsourced services that utilize analytical instruments to analyze biological and chemical samples.

Buyer Products:

  • Amarin Development AB
  
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies  
Dermatology  
Antihistamines
Products that inhibit inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Hydroxyzine HCl
  • Hydroxyzine Pamoate
  • Promethazine
  
Ophthalmology  
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Promethazine
  
Upper Respiratory  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Aller-Chlor (Chlorpheniramine)
  • Diphenhydramine HCl
  • Promethazine
  • Diphenist (Diphenhydramine)
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Allerfrim FC (Triprolidine/Pseudoephedrine)
  • Bromaline (Brompheniramine Maleate/Phenylpropanolamine Hydrocholride
  
Antihistamines/Decongestants/Antitussives
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.

Buyer Products:

  • Kidkare Cough & Cold Liquid (Chlorpheniramine Maleate/Pseudoephedrine HCL/Dextromethorphan Hydrobromide)
  
Cardiovascular System
Heart Disorders  
Angina  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Atenolol
  • Metoprolol Tartrate
  • Propranolol HCl
  
Calcium Channel Blocking Agents
Therapeutics that treat chest pains by preventing the entry of calcium into heart muscle cells.

Buyer Products:

  • Dilacor XR (Diltiazem HCl)
  • Nifedipine ER
  • Verapamil HCl/HCl SR
  • Diltiazem HCl
  
Arrhythmia  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat abnormal rhythm of the heart beat by inhibiting the stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol HCl
  
Calcium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of calcium into heart muscle cells.

Buyer Products:

  • Verapamil HCl/HCl SR
  
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.

Buyer Products:

  • Quinidine Gluconate ER
  • Quinidine Sulfate
  
Sodium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of sodium into heart muscle cells.

Buyer Products:

  • Disopyramide Phosphate
  • Propafenone HCl
  • Mexiletine HCl
  
Heart Failure (HF)  
Adjunctive Treatments  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that assist in the primary treatment of the ineffective pumping of the heart by inhibiting the renin-angiotensin system.

Buyer Products:

  • Lisinopril
  • Fosinopril Sodium
  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat the ineffective pumping of the heart by inhibiting the renin-angiotensin system.

Buyer Products:

  • Enalapril Maleate
  • Fosinopril Sodium
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat the ineffective pumping of the heart by blocking beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Carvedilol
  
Complications  
Edema  
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of water and sodium, but not potassium in urine.

Buyer Products:

  • Triamterene/Hydrochlorothiazide
  
Sulfonamide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Indapamide
  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Metolazone
  
Myocardial Infarction (MI)  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat irreversible damage to the heart muscle by inhibiting the renin-angiotensin system.

Buyer Products:

  • Lisinopril
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat irreversible damage to the heart muscle by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Atenolol
  • Metoprolol Tartrate
  • Propranolol HCl
  • Carvedilol
  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that treat irreversible damage to the heart muscle by preventing the synthesis of cholesterol.

Buyer Products:

  • Pravastatin Sodium
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in early stages of clinical research where human subject is involved.

Target Products:

  • Urocortin 2
  
Vascular Disorders  
Atherosclerosis  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that treat the narrowing or hardening of the arteries by preventing the synthesis of cholesterol.

Buyer Products:

  • Pravastatin Sodium
  
Hypertension  
Alpha Adrenergic Receptor Agonists
Therapeutics that treat high blood pressure by stimulating the alpha adrenergic receptors of the heart muscle.

Buyer Products:

  • Guanfacine HCl
  
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)
Therapeutics that treat high blood pressure by blocking alpha adrenergic receptors of the heart muscle.

Buyer Products:

  • Doxazosin Mesylate
  
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)/Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking alpha and beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Labetalol
  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system.

Buyer Products:

  • Enalapril Maleate
  • Lisinopril
  • Fosinopril Sodium
  
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system and increasing the excretion of sodium ions, potassium ions, and water through urine.

Buyer Products:

  • Fosinopril Sodium/Hydrochlorothiazide
  • Lisinopril/Hydrochlorothiazide
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Atenolol
  • Carvedilol
  • Propranolol HCl
  • Metoprolol Tartrate
  
Beta Receptor Blocking Agents (Beta Blockers)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.

Buyer Products:

  • Atenolol/Chlorthalidone
  • Bisoprolol Fumarate/Hydrochlorothiazide
  
Calcium Channel Blocking Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.

Buyer Products:

  • Dilacor XR (Diltiazem HCl)
  • Diltiazem HCl
  • Verapamil HCl/HCl SR
  
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of water and sodium, but not potassium in urine.

Buyer Products:

  • Amiloride Hydrochloride/Hydrochlorothiazide
  • Triamterene/Hydrochlorothiazide
  
Sulfonamide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Indapamide
  
Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Microzide (Hydrochlorothiazide)
  
Vasodilatory Agents
Therapeutics that treat high blood pressure by causing relaxation of the blood vessels.

Buyer Products:

  • Minoxidil
  
Tremors  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that prevent or treat involuntary trembling by blocking the beta adrenergic receptors in muscle tissue.

Buyer Products:

  • Propranolol HCl
  
Dermatology  
Acne  
Vulgaris  
Estrogens/Progestins
Therapeutics that treat acne by providing estrogen and progestin.

Buyer Products:

  • TriNessa (Norgestimate/Ethinyl Estradiol)
  
Keratolytic Agents
Therapeutics that soften, separate, and cause the shedding of skin.

Buyer Products:

  • Benzoyl Peroxide
  
Hair Disorders  
Alopecia (Hair Loss)  
5 Alpha Reductase Inhibitors
Therapeutics that treat hair loss by blocking the action of an enzyme that converts testosterone to a testosterone derivative.

Buyer Products:

  • Finasteride
  
Lesion/Scaling Disorders  
Dermatitis  
Atopic (Eczema)  
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat atopic dermatoses by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site.

Buyer Products:

  • Hydrocortisone
  • Hydroskin (Hydrocortisone)
  
Seborrheic (Dandruff)  
Anti-Mitotic Agents
Therapeutics that block the mitotic division of cells.

Buyer Products:

  • Selenium Sulf
  
Dermatoses  
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that counteract or suppress inflammation by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site.

Buyer Products:

  • Cordran (Flurandrenolide)
  • Cormax (Clobetasol Propionate)
  • Hydroskin (Hydrocortisone)
  • Hydrocortisone
  
Diaper Rash  
Zinc Oxide
Therapeutics that treat diaper rash by forming a protective barrier against the skin.

Buyer Products:

  • Zinc Oxide
  
Digestive System
Gall Bladder Disorders  
Cholelithiasis (Gallstones)  
Anticholelithic Agents
Therapeutics that treat gall stones by decreasing the liver's cholesterol synthesis and secretion.

Buyer Products:

  • Actigall (Ursodiol)
  • Ursodiol
  
Gastrointestinal Tract Disorders  
Gastroduodenal Disorders  
Peptic Ulcers  
Duodenal  
H2 Receptor Antagonists
Therapeutics that treat peptic ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Buyer Products:

  • Famotidine
  • Nizatidine
  • Ranitidine
  
Ulcer Adhering Agents
Therapeutics that treat peptic ulcers by binding to it and protecting it from further damage.

Buyer Products:

  • Sucralfate
  
Gastric  
H2 Receptor Antagonists
Therapeutics that treat peptic ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Buyer Products:

  • Famotidine
  • Nizatidine
  • Ranitidine
  
Zollinger-Ellison Syndrome  
H2 Receptor Antagonists
Therapeutics that treat ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Buyer Products:

  • Famotidine
  • Ranitidine
  
Gastroesophageal Disorders  
Abdominal Gas  
Acid Neutralizing Agents/Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat abdominal gas by reducing the acidity of the stomach as well as lowering the surface tension of gas bubbles in the bowels.

Buyer Products:

  • Almacone (Calcium Carbonate/Magnesium Hydroxide)
  • Lowsium Plus (Magaldrate/Simethicone)
  
Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat abdominal gas by reducing the surface tension of gas bubbles in the bowels.

Buyer Products:

  • Simethicone
  
Acid Indigestion/Heartburn  
Acid Neutralizing Agents
Therapeutics that treat heartburn by neutralizing stomach acid.

Buyer Products:

  • Alenic Alka (Aluminum Hydroxide/Magnesium Carbonate)
  • Sodium Bicarbonate
  • Magnesium Hydroxide/Aluminium Hydroxide
  • Cal-Gest (Calcium Carbonate)
  • Aluminum Hydroxide Gel
  
Acid Neutralizing Agents/Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat indigestion by neutralizing the stomach acid as well as lowering the surface tension of the gas bubbles in the bowels.

Buyer Products:

  • Lowsium Plus (Magaldrate/Simethicone)
  
H2 Receptor Antagonists
Therapeutics that treat indigestion by blocking the action of histamine at the H2 receptors.

Buyer Products:

  • Famotidine
  • Nizatidine
  
Erosive Esophagitis  
H2 Receptor Antagonists
Therapeutics that treat Erosive Esophagitis by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Buyer Products:

  • Nizatidine
  • Ranitidine
  
Gastroesophageal Reflux Disease (GERD)  
H2 Receptor Antagonists
Therapeutics that treat Gastroesophageal Reflux Disease by inhibiting the actions of receptors responsible for triggering acid release into the stomach.

Buyer Products:

  • Famotidine
  • Ranitidine
  • Nizatidine
  
Nausea/Vomiting  
Antiemetic Agents
Therapeutics that treat nausea or vomiting by acting locally on the hyperactive gastrointestinal wall.

Buyer Products:

  • Kalmz Liquid (Phosphorylated Carbohydrate)
  
Intestinal Disorders  
Constipation  
Chronic  
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.

Buyer Products:

  • Fiber-Lax (Calcium Polycarbophil)
  • Reguloid (Psyllium)
  
Impacted Bowels  
Hyperosmotic Agents
Therapeutics that treat constipation by causing fluid overload, which in turn induces liquid stool within a short period of time.

Buyer Products:

  • Lactulose Solution
  • Milk of Magnesia (Magnesium Hydroxide)
  
Stimulants
Therapeutics that treat constipation by stimulating the contraction of bowels by addition of fiber or other substances.

Buyer Products:

  • Laxative EC (Bisacodyl)
  • Senexon (Senna)
  • Bisacodyl
  
Stool Softeners
Therapeutics that treat constipation by increasing the absorption of moisture into feces to form a softer body.

Buyer Products:

  • Diocto Syrup (Docusate sodium)
  • Doc Cal (Calcium Docusate)
  • Doc Sod & Senna (Docusate sodium)
  
Irregular Bowel Movements  
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.

Buyer Products:

  • Fiber-Lax (Calcium Polycarbophil)
  • Reguloid (Psyllium)
  
Stimulants
Therapeutics that treat constipation by stimulating the contraction of bowels by addition of fiber or other substances.

Buyer Products:

  • Laxative EC (Bisacodyl)
  • Senexon (Senna)
  • Bisacodyl
  
Diarrhea  
Adsorbents
Therapeutics that treat diarrhea by promoting the uptake of water from the intestines.

Buyer Products:

  • K-Pek Suspension (Attapulgite)
  
Antiperistaltic Agents
Therapeutics that treat diarrhea by inhibiting the wavelike motion of the digestive tract.

Buyer Products:

  • K-Pek (Loperamide Hydrochloride)
  • Loperamide HCl Oral Solution
  
Antisecretory Agents
Therapeutics that treat diarrhea by bringing fluid movement within the intestine to normal levels.

Buyer Products:

  • Peptic Relief Chew Tablets (Bismuth Subsalicylate)
  
Inflammatory Bowel Disease (IBD)  
Ulcerative Colitis  
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat ulcerative colitis by inhibiting the actions of the two enzymes, cyclooxygenase and lipoxygenase.

Buyer Products:

  • Sulfasalazine
  
Irritable Bowel Syndrome (IBS)  
Anticholinergic Agents
Therapeutics that treat irritable bowel syndrome by decreasing the liver's cholesterol synthesis and secretion.

Buyer Products:

  • Dicyclomine HCl
  
Rectal Disorders  
Hemorrhoids  
Alpha Adrenergic Receptor Agonists
Therapeutics that treat hemorrhoids by stimulating the alpha adrenergic receptors.

Buyer Products:

  • Hemorrhoidal Suppositories
  
Liver Disorders  
Cirrhosis  
Complications  
Edema  
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium and water, but not potassium in urine.

Buyer Products:

  • Triamterene/Hydrochlorothiazide
  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Hydrochlorothiazide
  • Microzide (Hydrochlorothiazide)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of digestive disorders in very early stages of research where no human subject is involved.

Target Products:

  • CRF R1 Antagonist
  
Endocrinology/Metabolism
Diabetes  
Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes  
Biguanides
Therapeutics that treat abnormally high blood glucose levels by decreasing the production of glucose in the liver, decreasing intestinal absorption of glucose and increasing peripheral uptake and utilization of glucose.

Buyer Products:

  • Metformin HCL
  
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that treat non-insulin dependent diabetes by stimulating the secretion of insulin.

Buyer Products:

  • Glipizide/Glipizide Extended-Release
  
Peroxisome Proliferator-Activated Receptor Agonists (PPAR Agonists)
Products that sensitizes organs to insulin.

Buyer Products:

  • Pioglitazone Hydrochloride
  
General Hormone Treatments  
Prednisolones
Therapeutics that treat inflammation by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.

Buyer Products:

  • Methylprednisolone
  • Prednisolone
  
Prednisones
Therapeutics that treat inflammation by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.

Buyer Products:

  • Prednisone
  
Hyperglycemia  
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that stimulate the secretion of insulin.

Buyer Products:

  • Glipizide/Glipizide Extended-Release
  
Intermediary Metabolism Disorders  
Gout  
Gouty Arthritis  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that counteract or suppress inflammation preventing cyclooxygenase activity.

Buyer Products:

  • Naproxen Sodium
  • Sulindac
  
Urate Crystalization Inhibitors
Therapeutics that treat gouty arthritis by preventing the deposition of urate crystals in the joints.

Buyer Products:

  • Colchicine
  
Urate Resorption Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate.

Buyer Products:

  • Probenecid
  
Urate Resorption Inhibitors/Urate Crystallization Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate as well as preventing the deposition of excess urate crystals in the joints.

Buyer Products:

  • Probenecid/Colchicine
  
Hyperuricemia  
Urate Resorption Inhibitors
Therapeutics that inhibit the resorption of urate from the kidneys.

Buyer Products:

  • Probenecid
  
Xanthine Oxidase Inhibitors
Therapeutics that inhibit the resorption of urate from the kidneys and prevent the precipitation of urate in the joint.

Buyer Products:

  • Allopurinol
  
Hypercholesterolemia  
Free Fatty Acid Inhibitors
Therapeutics that treat the abnormally high concentrations of cholesterol by inhibiting the release of fatty acids from adipose tissue.

Buyer Products:

  • Niacin
  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.

Buyer Products:

  • Pravastatin Sodium
  
Hyperlipidemia  
Free Fatty Acid Inhibitors
Therapeutics that inhibit the release of fatty acids from adipose tissue.

Buyer Products:

  • Niacin
  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.

Buyer Products:

  • Pravastatin Sodium
  
Plasma Triglyceride Reducing Agents (Fibrate Compounds)
Therapeutics that reduce the levels of very low-density lipoprotein and increase levels of high-density lipoproteins.

Buyer Products:

  • Gemfibrozil
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.

Target Products:

  • NBI-6024 (Altered Peptide Ligand)
  
Reproductive Disorders  
Amenorrhea  
Progestins
Female sex hormone necessary for the development of the female reproductive system.

Buyer Products:

  • Progesterone Injection
  
Hypoestrogenism  
Hormonal Treatments  
Estrogens
Therapeutics that are female sex hormones.

Buyer Products:

  • Alora (Estradiol Transdermal Patch)
  • Estradiol
  
Hypogonadism  
Male  
Androgens
Therapeutics that are male sex hormones.

Buyer Products:

  • Androderm (Testosterone Transdermal System)
  • Testosterone Gel
  
Menopause  
Estrogens
Therapeutics that are female sex hormones.

Buyer Products:

  • Alora (Estradiol Transdermal Patch)
  • Estradiol
  • Estropipate
  
Hematology  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Ferrlecit (Sodium Ferric Gluconate Complex)
  
Red Blood Cell (RBC) Disorders  
Anemia  
Iron Supplements
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues caused by iron deficiency by replacing missing iron.

Buyer Products:

  • Ferrlecit (Sodium Ferric Gluconate Complex)
  • Infed (Iron Dextran Injection)
  
Serum Factor Disorders  
Hypercholesterolemia  
Free Fatty Acid Inhibitors
Therapeutics that treat the abnormally high concentrations of cholesterol by inhibiting the release of fatty acids from adipose tissue.

Buyer Products:

  • Niacin
  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.

Buyer Products:

  • Pravastatin Sodium
  
Hyperglycemia  
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that stimulate the secretion of insulin.

Buyer Products:

  • Glipizide/Glipizide Extended-Release
  
Hyperlipidemia  
Free Fatty Acid Inhibitors
Therapeutics that inhibit the release of fatty acids from adipose tissue.

Buyer Products:

  • Niacin
  
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.

Buyer Products:

  • Pravastatin Sodium
  
Plasma Triglyceride Reducing Agents (Fibrate Compounds)
Therapeutics that reduce the levels of very low-density lipoprotein and increase levels of high-density lipoproteins.

Buyer Products:

  • Gemfibrozil
  
Hyperuricemia  
Urate Resorption Inhibitors
Therapeutics that prevents the resorption of urate within the kidneys.

Buyer Products:

  • Probenecid
  
Xanthine Oxidase Inhibitors
Therapeutics that treat hyperuricemia by preventing the conversion of hypoxanthine to uric acid.

Buyer Products:

  • Allopurinol
  
Thrombocyte (Platelet) Disorders  
Thrombocythemia  
Megakaryocyte Maturation Inhibitors
Therapeutics that prevents the maturation of platelet producing cells.

Buyer Products:

  • Anagrelide
  
Immunology
Autoimmune Disorders  
Arthritis  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Buyer Products:

  • Diclofenac Sodium
  • Sulindac
  • Meclofenamate Sodium
  • Naproxen Sodium
  • Piroxicam
  
Immunotherapy  
Immunosuppressants
Therapeutics that treat chronic inflammation of the joints by inhibiting a full immune response.

Buyer Products:

  • Sulfasalazine
  
Inflammatory Bowel Disease (IBD)  
Ulcerative Colitis  
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat inflammation of the colon and rectum by blocking the action of cyclooxygenase and lipoxygenase.

Buyer Products:

  • Sulfasalazine
  
Lupus Erythematosus  
Systemic (SLE)  
Hormonal
Therapeutics that treat systemic lupus with hormones.

Buyer Products:

  • Prestara (Prasterone)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in early stages of clinical research where human subject is involved.

Target Products:

  • NBI-5788 (Altered Peptide Ligand)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in very early stages of research where no human subject is involved.

Target Products:

  • CCR7
  
Infectious Diseases  
Bacterial  
Antibacterial Agents  
Broad Spectrum  
Antibiotics  
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Buyer Products:

  • Cefazolin For Injection
  • Cefuroxime Axetil
  • Triple Antibiotic Ointment (Polymyxin B Sulfate)
  
Lincosamides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.

Buyer Products:

  • Clindamycin HCl
  
Nitroimidazoles
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis and causing cell death.

Buyer Products:

  • Metronidazole
  
Sulfonamides
Therapeutics that treat a wide variety of bacterial infections by inhibiting folic acid synthesis.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Tetracyclines
Therapeutics that treat a wide variety of infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.

Buyer Products:

  • Doxycycline Hyclate
  • Monodox (Doxycycline Monohydrate)
  • Doxycycline Monohydrate
  • Minocycline HCl
  
Narrow Spectrum  
Dermatology  
Skin/Soft Tissue Infections  
Sulfonamides
Therapeutics that treat specific bacterial infections by inhibiting folic acid synthesis.

Buyer Products:

  • Silver Sulfadiazine
  
Musculoskeletal System  
Skin/Soft Tissue Infections  
Sulfonamides
Therapeutics that treat bacterial infections of non-skeletal tissue usually involving fat, muscle, and skin by inhibiting folic acid synthesis.

Buyer Products:

  • Silver Sulfadiazine
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Nitrofurantoins
Therapeutics that treat bacterial infections of the urinary tract by inactivating/altering bacterial proteins and other macromolecules.

Buyer Products:

  • Nitrofurantoin/Macrocrystals
  
Trimethoprim
Therapeutics that treat bacterial infections of the urethra, urinary bladder, ureters, and kidneys by blocking the action of bacterial dihydrofolate reductase.

Buyer Products:

  • Trimethoprim
  
Mycological (Fungal)  
Antifungal Agents  
Narrow Spectrum  
Dermatology  
Tinea Corporis (Ringworm)  
Thiocarbamates
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by stunting the growth of the branching filaments.

Buyer Products:

  • Tolnaftate
  
Tinea Cruris (Jock Itch)  
Thiocarbamates
Therapeutics that treat fungal infections of the groin and perineum by stunting the growth of the branching filaments.

Buyer Products:

  • Tolnaftate
  
Tinea Pedis  
Thiocarbamates
Therapeutics that treat fungal infections of the feet by stunting the growth of the branching filaments.

Buyer Products:

  • Tolnaftate
  
Urology  
Vaginal Candidiasis  
Azoles  
Imidazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Miconazole-7 Vaginal Cream (Miconazole Nitrate)
  
Triazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Terconazole Cream
  
Protozoal  
Antiprotozoal Agents  
Broad Spectrum  
Nitroimidazoles
Therapeutics that treat infections caused by a wide variety of unicellular organisms by inhibiting protein synthesis and causing cell death.

Buyer Products:

  • Metronidazole
  
Tetracyclines
Therapeutics that treat infections caused by a wide variety of unicellular organisms by inhibiting protein synthesis and causing cell death.

Buyer Products:

  • Doxycycline Hyclate
  • Minocycline HCl
  • Monodox (Doxycycline Monohydrate)
  
Narrow Spectrum  
Malaria  
Quinines
Therapeutics that treat parasitic infections caused by Plasmodia in red blood cells by disrupting replication and transcription.

Buyer Products:

  • Quinine Sulfate
  
Viral  
DNA Viruses  
Herpesvirus  
Herpes Simplex Type 1  
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Herpes Simplex Type 2  
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Varicella Zoster  
Herpes Zoster (Shingles)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause shingles in adults by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Varicella (Chickenpox)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause chicken pox in children by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Papillomavirus  
Genital Warts  
Podophyllins
Therapeutics that treat viral infections that cause genital warts by eroding skin lesions.

Buyer Products:

  • Condylox (Podofilox)
  
Musculoskeletal System  
Skeletal Disorders  
Bone Disorders  
Osteoporosis  
Hormonal Treatments  
Estrogens
Therapeutics that treat osteoporosis by providing female hormones which results in a decrease in the rate of bone loss due to osteoclasts.

Buyer Products:

  • Estradiol
  • Estropipate
  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat osteoporosis by preventing loss of bone mass due to osteoclasts.

Buyer Products:

  • Alendronate Sodium
  
Paget`s Disease  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat paget's disease by inhibiting the loss of bone material by osteoclasts.

Buyer Products:

  • Alendronate Sodium
  
Joint Disorders  
Ankylosing Spondylitis  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Naproxen Sodium
  • Sulindac
  
Gouty Arthritis  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by inhibiting cyclooxygenase activity.

Buyer Products:

  • Naproxen Sodium
  • Sulindac
  
Urate Crystalization Inhibitors
Therapeutics that treat gouty arthritis by preventing the deposition of urate crystals in the joints.

Buyer Products:

  • Colchicine
  
Urate Resorption Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate.

Buyer Products:

  • Probenecid
  
Urate Resorption Inhibitors/Urate Crystallization Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate as well as preventing the deposition of excess urate crystals in the joints.

Buyer Products:

  • Probenecid/Colchicine
  
Osteoarthritis (OA)  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Diclofenac Sodium
  • Naproxen Sodium
  • Sulindac
  • Meclofenamate Sodium
  • Piroxicam
  
Substance P Inhibitors
Therapeutics that treat inflammation by preventing the accumulation of Substance P at the inflammation sites.

Buyer Products:

  • Capsaicin
  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Buyer Products:

  • Diclofenac Sodium
  • Naproxen Sodium
  • Sulindac
  • Meclofenamate Sodium
  • Piroxicam
  
Immunotherapy  
Immunosuppressants
Therapeutics that treat rheumatoid arthritis by suppressing the immune system.

Buyer Products:

  • Sulfasalazine
  
Neurology
Neurological Disorders  
Alzheimer`s Disease  
Acetylcholinesterase Inhibitors
Therapeutics that treat Alzheimer's Disease by preventing the breakdown of a the neurotransmitter, acetylcholine.

Buyer Products:

  • Rivastigmine
  
Epilepsy  
Partial Seizures  
Complex  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid, which prevent nerve activation.

Buyer Products:

  • Clorazepate Dipotassium
  • Gabapentin
  
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid as well as blocking the sodium channels which in turn block the conductance of electrical impulses through the brain.

Buyer Products:

  • Zonisamide
  
Monotherapy  
Barbiturates
Therapeutics that treat complex partial seizures by decreasing excitability of neurons.

Buyer Products:

  • Primidone
  
Simple  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat simple partial seizures by preventing the uptake of gamma-aminobutyric acid which prevents nerve activation.

Buyer Products:

  • Clorazepate Dipotassium
  
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat simple partial seizure by both preventing the uptake of gamma-aminobutyric acid which prevents nerve activation as well as blocking the sodium channels which in turn block the conductance of neural impulses.

Buyer Products:

  • Zonisamide
  
Monotherapy  
Barbiturates
Therapeutics that treat simple partial seizures by decreasing excitability of neurons.

Buyer Products:

  • Primidone
  
Primary Generalized Seizures  
Absence (Petit Mal)  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Petit Mal Seizures by preventing the uptake of molecules that prevents nerve activation.

Buyer Products:

  • Clonazepam
  • Valproic Acid
  
Monotherapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Petit Mal Seizures by preventing the uptake of molecules that prevents nerve activation.

Buyer Products:

  • Clonazepam
  
Akinetic Pattern  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Akinetic Pattern Seizures by preventing the uptake of molecules that prevents nerve activation.

Buyer Products:

  • Clonazepam
  
Monotherapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Akinetic Pattern Seizures by preventing the uptake of molecules that prevents nerve activation.

Buyer Products:

  • Clonazepam
  
Myoclonic  
Adjunctive Therapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Myoclonic Seizures by inhibiting the uptake of molecules that prevent nerve activation.

Buyer Products:

  • Clonazepam
  
Monotherapy  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Myoclonic Seizures by inhibiting the uptake of molecules that prevents nerve activation.

Buyer Products:

  • Clonazepam
  
Tonic-Clonic (Grand Mal)  
Barbiturates
Therapeutics that treat tonic clonic seizures by acting as sedatives through nonselective suppression of central nervous system activities.

Buyer Products:

  • Primidone
  
Headaches  
Tension Type  
Barbiturates/Analgesics/Antipyretics/Opioids/Stimulants
Therapeutics that treat tension type headaches by decreasing the excitability of neurons, decreasing pain by inhibiting the production of prostaglandins as well as stimulating the opioid receptors.

Buyer Products:

  • Fioricet With Codeine (Butalbital/Acetaminophen/Codeine/Caffeine)
  
Barbiturates/Analgesics/Antipyretics/Stimulants
Therapeutics that treat tension type headaches by decreasing the excitability of neurons and decreasing pain by inhibiting the production of prostaglandins.

Buyer Products:

  • Fioricet (Butalbital/Acetaminophen/Caffeine)
  
Barbiturates/Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Opioids/Stimulants
Therapeutics that treat pain by depressing neural activity, preventing inflammation and fever, altering the perception of and emotional response to pain, and stimulating the central nervous system.

Buyer Products:

  • Fiorinal With Codeine (Butalbital/Aspirin/Codeine/Caffeine)
  • BACC (Butalbital/Aspirin/Codeine Phosphate/Caffeine)
  
Barbiturates/Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Stimulants
Therapeutics that treat tension type headaches by decreasing the excitability of neurons as well as decreasing pain by inhibiting the production of prostaglandins.

Buyer Products:

  • Fiorinal (Butalbital/Aspirin/Caffeine)
  
Vascular (Migraine)  
Prophylactic Treatments  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat Migraine by inhibiting stimulation of beta adrenergic receptors.

Buyer Products:

  • Propranolol HCl
  
Motion Sickness  
Anticholinergic Agents
Therapeutics that treat motion sickness by selectively deterring actions of the involuntary nervous system.

Buyer Products:

  • Dimenhydrinate
  
Antivertigo Agents
Therapeutics that prevent the sensation of motion.

Buyer Products:

  • Meclizine HCl
  • Meclizine OTC
  
Spasticity (Spinal Shock)  
Aspartic Receptor Antagonists/Glutamic Receptor Antagonists
Therapeutics that treat Spinal Shock by blocking the receptors for aspartic acid and glutamic acid, both excitatory neurotransmitters.

Buyer Products:

  • Baclofen
  
Neuromuscular Disorders  
Myasthenia Gravis (MG)  
Cholinesterase Inhibitors
Therapeutics that treat Myasthenia Gravis by maintaining the transmission of nerve impulses by inhibiting the enzyme that breaks down acetylcholine.

Buyer Products:

  • Pyridostigmine Bromide
  
Parkinson`s Disease (PD)  
Adjunctive Treatments  
Cholinergic Receptor Blocking Agents
Therapeutics that assist in the treatment of the disorder involving nerve cell loss in portions of the brain that leads to uncontrolled tremors, abnormal posture and speech problems by blocking acetylcholine receptors on neurons.

Buyer Products:

  • Trihexyphenidyl
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of nervous system and mental disorders in early stages of clinical research where human subject is involved.

Target Products:

  • NBI-75043
  • NBI-34041 (CRF R1 Antagonist)
  • NBI-5788 (Altered Peptide Ligand)
  • CRF R1 Antagonist
  
Psychiatric Disorders
Anxiety  
Generalized Anxiety Disorder (GAD)  
Antihistamines
Therapeutics that treat anxiety by blocking the action of histamines.

Buyer Products:

  • Hydroxyzine HCl
  • Hydroxyzine Pamoate
  
Carbamate Derivatives
Therapeutics that treat anxiety by blocking the NMDA receptor thus blocking the effects of excitatory amino acids and suppressing seizure activity.

Buyer Products:

  • Meprobamate
  
Dopamine Receptor Blocking Agents
Therapeutics that treat anxiety by blocking dopamine receptors.

Buyer Products:

  • Buspirone
  
Dopamine Receptor Blocking Agents/Tricyclic Antidepressants
Therapeutic combinations that treat anxiety by blocking dopamine receptors as well as increasing the synaptic concentrations of norepinephrine and serotonin.

Buyer Products:

  • Perphenazine/Amitriptyline HCl
  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat anxiety by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Chlordiazepoxide HCl
  • Clorazepate Dipotassium
  • Diazepam
  • Lorazepam
  
Tricyclic Compounds
Therapeutics that treat anxiety by increasing the synaptic concentrations of norepinephrine and serotonin.

Buyer Products:

  • Doxepin HCl
  
Obsessive Compulsive Disorder (OCD)  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat Anxiety by selectively preventing the removal of serotonin.

Buyer Products:

  • Fluoxetine
  
Panic Disorder  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat panic disorder by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Clonazepam
  
Childhood/Adolescent Disorders  
Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD)  
Dopamine Receptor Blocking Agents
Therapeutics that treat attention deficit disorder by blocking the dopamine receptors.

Buyer Products:

  • Methylphenidate HCl
  
Eating Disorders  
Bulimia  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat eating disorders by selectively preventing the removal of serotonin.

Buyer Products:

  • Fluoxetine
  
Mood Disorders  
Bipolar Disorders (Manic Depressive Disorders)  
Tricyclic Compounds
Therapeutics that treat bipolar disorders by increasing the synaptic concentrations of norepinephrine and serotonin.

Buyer Products:

  • Doxepin HCl
  
Depression  
Dopamine Receptor Blocking Agents/Tricyclic Antidepressants
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine and serotonin and by blocking the receptor for dopamine.

Buyer Products:

  • Perphenazine/Amitriptyline HCl
  
Monoamine Oxidase (MAO) Inhibitors
Therapeutics that treat depression by inhibiting the activity of monoamine oxidase, which degrades neurotransmitters.

Buyer Products:

  • Somerset Pharmaceuticals Emsam (Selegiline Transdermal System)
  
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat depression by selectively preventing the removal of serotonin.

Buyer Products:

  • Fluoxetine
  • Citalopram Hydrobromide
  • Trazodone HCl
  
Serotonin/Norepinephrine Reuptake Inhibitors
Therapeutics that treat depression by inhibiting the neuronal uptake of serotonin and norepinephrine.

Buyer Products:

  • Bupropion Hydrochloride Sustained Release
  • Nefazodone
  
Tetracyclic Compounds
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine.

Buyer Products:

  • Mirtazapine
  
Tricyclic Compounds
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine and serotonin.

Buyer Products:

  • Amoxapine
  • Doxepin HCl
  • Nortriptyline HCl
  
Schizophrenia  
Dopamine Receptor Blocking Agents
Therapeutics that treat schizophrenia by blocking the dopamine receptors.

Buyer Products:

  • Loxapine Succinate
  • Loxitane (Loxapine Succinate)
  
Dopamine Receptor Blocking Agents/Tricyclic Antidepressants
Therapeutic combinations that treat the disorder involving disturbances in thoughts, emotions and reasoning by blocking dopamine receptors as well as increasing the synaptic concentrations of norepinephrine and serotonin.

Buyer Products:

  • Perphenazine/Amitriptyline HCl
  
Sleep Disorders
Insomnia
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.

Buyer Products:

  • Estazolam

Target Products:

  • Indiplon Immediate Release Capsule
  • Indiplon Modified Release Tablet
Narcolepsy  
Dopamine Receptor Blocking Agents
Therapeutics that treat Narcolepsy by blocking the dopamine receptors.

Buyer Products:

  • Methylphenidate HCl
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of nervous system and mental disorders in very early stages of research where no human subject is involved.

Target Products:

  • Adenosine 2A Receptor Antagonists
  • Sleep Program
  • Excitatory Amino Acid Transporters
  • CRF R2 Antagonist
  • MC-4 (Melanin Concentrating Hormone Antagonist)
  • Melanocortin Receptor Agonist
  
Obstetrics/Gynecology
Child Birth/Pregnancy  
Prevention (Contraception)  
Contraceptives (Birth Control)  
Estrogens/Progestins
Therapeutics that prevent conception by decreasing the secretion of gonadotropin-releasing hormone in the hypothalamus, resulting in an anti-ovulatory effect.

Buyer Products:

  • Brevicon (Norethindrone/Ethinyl Estradiol)
  • Tri-Norinyl (Ethinyl Estradiol/Norethindrone)
  • Zovia (Ethinyl Estradiol/Ethynodiol Diacetate)
  • TriNessa (Norgestimate/Ethinyl Estradiol)
  • Ethinyl Estradiol/Desogestrel
  • Levonorgestrel/Ethinyl Estradiol
  • Mononessa (Norgestimate/Ethinyl Estradiol)
  • Microgestin FE (Norethindrone/Ethinyl Estradiol)
  • Trivora (Ethinyl Estradiol/Levonorgestrel)
  • Ogestrel (Norgestrel/Ethinyl Estradiol)
  • Norinyl (Norethindrone/Ethinyl Estradiol)
  • Low-Ogestrel (Norgestrel/Ethinyl Estradiol)
  • Necon (Norethindrone/Ethinyl Estradiol)
  • Levora (Ethinyl Estradiol/Levonorgestrel)
  
Progestins
Contraceptive Therapeutics that are female sex hormone necessary for the development of the female reproductive system

Buyer Products:

  • Nor-QD (Norethindrone)
  • Jolivette (Norethindrone)
  
Female Genital Disorders  
Infertility  
Hormonal Treatments  
Ovulation Stimulating Agents
Therapeutics that treat infertility by stimulating the ovaries to release a mature egg.

Buyer Products:

  • Clomiphene Citrate
  
Ovarian  
Hypogonadism  
Hormonal Treatments  
Estrogens
These are female sex hormones.

Buyer Products:

  • Alora (Estradiol Transdermal Patch)
  • Estradiol
  • Estropipate
  
Sexual Dysfunction  
Androgens
Therapeutics that treat female sexual dysfunction by providing male sex hormone, such as testosterone, that is important for the normal functioning of the female reproductive system.

Buyer Products:

  • Intrinsa (Testosterone Patch)
  
Vulvovaginal  
Atrophy  
Hormonal Treatments  
Estrogens
Therapeutics that treat disorders characterized by thinning of the vaginal walls with the female sex hormone estrogen.

Buyer Products:

  • Alora (Estradiol Transdermal Patch)
  • Estropipate
  • Estradiol
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of female reproductive disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Contraception Patch

Target Products:

  • D2 Receptor Agonist
  • NBI-56418 (GnRH Antagonist)
  • NBI-42902 (GnRH Antagonist)
Oncology
Breast Cancer  
Palliative Agents  
Hormonal Treatments  
Estrogens
Therapeutics that treat and manage breast cancer in post-menopausal women by providing female hormones.

Buyer Products:

  • Estradiol
  
Hematology  
Leukemia  
Palliative Agents  
Xanthine Oxidase Inhibitors
Therapeutics that treat renal toxicity associated with chemotherapy by preventing the formation of uric acid from xanthine.

Buyer Products:

  • Allopurinol
  
Lymphoma  
Hodgkin`s Disease  
Palliative Agents  
Xanthine Oxidase Inhibitors
Therapeutics that treat renal toxicity associated with chemotherapy for lymphoma characterized by the presence of Reed-Sternberg cells by preventing the formation of uric acid from xanthine.

Buyer Products:

  • Allopurinol
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer in early stages of clinical research where human subject is involved.

Target Products:

  • NBI-42902 (GnRH Antagonist)
  • NBI-3001 (IL-4 Fusion Toxin)
  
Urology  
Ovarian Cancer  
Adenocarcinoma  
Alkylating Agents  
Platinum-Based Agents
Platinum containing therapeutics that treat and manage cancer of cells lining the ovary by interacting with DNA and inhibiting cell division.

Buyer Products:

  • Carboplatin
  
Palliative Agents  
Alkylating Agents  
Platinum-Based Agents
Platinum containing therapeutics that treat and manage ovarian cancers by interacting with DNA and inhibiting cell division but are not curative.

Buyer Products:

  • Carboplatin
  
Prostate Cancer  
Palliative Agents  
Estrogens
Therapeutics that treat and manage prostate cancer by inhibiting the secretion of luteinizing hormone and affecting the testes so as to decrease serum concentrations of testosterone but are not curative.

Buyer Products:

  • Estradiol
  
Gonadotropin Releasing Hormone (GnRH) Antagonists
Therapeutics that treat and manage primary tumors of the prostate gland by blocking the action of gonadotropin releasing hormone and thus decreasing levels of testosterone.

Buyer Products:

  • Trelstar Depot/LA (Triptorelin Pamoate)
  
Ophthalmology  
Degenerative Disorders  
Dry Eye  
Lubricants
Therapeutics that wet the eye and lubricate the eye.

Buyer Products:

  • Artificial Tear Ophthalmic Ointment
  • Artificial Tear Solution
  
Glaucoma  
Carbonic Anhydrase Inhibitors
Therapeutics that decrease the formation of the fluid of the eye.

Buyer Products:

  • Acetazolamide
  
Irritation/Inflammation  
Vasoconstricting Agents
Therapeutics that prevent inflammation by constricting the blood vessels.

Buyer Products:

  • Tetrahydrozoline
  
Pain Management
Narcotics  
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • APAP/Hydrocodone Bitartrate
  • Hydrocodone/Ibuprofen
  • Maxidone (Hydrocodone Bitartrate/Acetaminophen)
  • Pentazocine/APAP
  • Propoxyphene/APAP
  • Oxycodone/Aspirin
  • Norco (Acetaminophen/Hydrocodone Bitartrate)
  • Oxycodone/APAP
  
Barbiturates/Analgesics/Antipyretics/Opioids/Stimulants
Therapeutics that treat pain by depressing neural activity, preventing inflammation and fever, altering the perception of and emotional response to pain, and stimulating the central nervous system.

Buyer Products:

  • Fioricet With Codeine (Butalbital/Acetaminophen/Codeine/Caffeine)
  
Barbiturates/Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Opioids/Stimulants
Therapeutics that treat pain by depressing neural activity, preventing inflammation and fever, altering the perception of and emotional response to pain, and stimulating the central nervous system.

Buyer Products:

  • Fiorinal With Codeine (Butalbital/Aspirin/Codeine/Caffeine)
  • BACC (Butalbital/Aspirin/Codeine Phosphate/Caffeine)
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Meperidine HCl
  • Tramadol Hydrochloride
  • Morphine Sulfate ER
  • Oxycodone HCl
  • Pentazocine/Naloxone HCl
  
Non-Narcotics  
Analgesics Combinations  
Analgesics/Antipyretics
Therapeutics that treat pain and fever by inhibiting the action of prostaglandins.

Buyer Products:

  • APAP
  • Aspirin
  • Acetaminophen
  
Barbiturates/Analgesics/Antipyretics/Stimulants
Therapeutic combinations that treat pain by depressing neural activity, preventing inflammation and fever, and stimulating the central nervous system.

Buyer Products:

  • Fioricet (Butalbital/Acetaminophen/Caffeine)
  
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat pain by inhibiting the reuptake of GABA, which increases the levels of GABA in the synapses.

Buyer Products:

  • Gabapentin
  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Ibuprofen
  • Meclofenamate Sodium
  • Sulindac
  • Naproxen Sodium
  
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.

Buyer Products:

  • Carisoprodol
  • Methocarbamol
  • Cyclobenzaprine HCl
  
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat pain by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.

Buyer Products:

  • Prednisolone
  • Prednisone
  
Substance P Inhibitors
Therapeutics that treat pain by inhibiting the accumulation of Substance P at the inflammation site.

Buyer Products:

  • Capsaicin
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of pain in very early stages of research where no human subject is involved.

Target Products:

  • Fractalkine
  
Respiratory System  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Amphetamines
Therapeutics that treat coughs and colds by helping to relieve nasal congestion.

Buyer Products:

  • Diphenhydramine HCl
  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Diphenist (Diphenhydramine)
  • Promethazine
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and reduces the amount of mucous build up.

Buyer Products:

  • Bromaline (Brompheniramine Maleate/Phenylpropanolamine Hydrocholride
  
Antihistamines/Decongestants/Antitussives
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.

Buyer Products:

  • Kidkare Cough & Cold Liquid (Chlorpheniramine Maleate/Pseudoephedrine HCL/Dextromethorphan Hydrobromide)
  
Decongestants
Therapeutics that treat coughs and colds by reducing mucous build up.

Buyer Products:

  • Kidkare Decongestant Drops (Pseudoephedrine HCl)
  • NRS-Nasal Relief Spray (Oxymetazoline)
  
Expectorants
Therapeutics that treat coughs and colds by helping in the ejection of mucous.

Buyer Products:

  • Guaifenesin Cough Syrup
  
Nasal Dryness  
Moisturizing Agents
Therapeutics that treat nasal dryness by providing moisture to the nasal passages.

Buyer Products:

  • Saline Mist
  
Surgery  
General  
Restlessness/Apprehension  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat the nervousness which precedes surgery by increasing the action of gamma aminobutyric acid at the relevant neuroreceptors.

Buyer Products:

  • Chlordiazepoxide HCl
  
Toxicology  
Substance Abuse  
Withdrawal  
Alcohol  
Antihistamines
Therapeutics that treat alcohol withdrawal by blocking the H2 receptors and thus the effects of histamines.

Buyer Products:

  • Hydroxyzine HCl
  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat alcohol withdrawal by increasing the effect of GABA at the relevant neuroreceptors.

Buyer Products:

  • Chlordiazepoxide HCl
  • Diazepam
  • Clorazepate Dipotassium
  
Nicotine (Smoking Cessation)  
Nicotinic Receptor Agonists
Therapeutics that treat nicotine withdrawal by activating nicotine receptors thus reducing cravings for nicotine.

Buyer Products:

  • Nicotine Transdermal System
  • Nicotine Polacriles Gum
  
Urology
Male Genital Disorders  
Prostate  
Benign Prostate Hyperplasia (BPH)  
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)
Therapeutics that increase blood flow by acting on the alpha adrenergic receptors thus causing the smooth muscle in the prostate to relax and decreasing the constriction on the urinary tract.

Buyer Products:

  • Doxazosin Mesylate
  • Silodosin
  
Testicular  
Failure  
Hormonal Treatments  
Androgens
Therapeutics that treat testicular failure by providing male sex hormones.

Buyer Products:

  • Androderm (Testosterone Transdermal System)
  
Hypogonadism  
Androgens
Therapeutics that treat hypogonadism by providing male sex hormones.

Buyer Products:

  • Androderm (Testosterone Transdermal System)
  • Testosterone Gel
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of urological disorders in early stages of clinical research where human subject is involved.

Target Products:

  • D2 Receptor Agonist
  • NBI-56418 (GnRH Antagonist)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of urological disorders in very early stages of research where no human subject is involved.

Target Products:

  • MC-4 (Melanin Concentrating Hormone Antagonist)
  
Urological Disorders  
Bladder  
Neurogenic Bladder Disease  
Anticholinergic Agents
Therapeutics that block the actions of choline and other cholinergic agents.

Buyer Products:

  • Oxybutynin Hydrochloride
  
Urinary Frequency/Urge Incontinence  
Anticholinergic Agents
Therapeutics that treat the inability to control urinary excretory functions by blocking the actions of choline and other cholinergic agents.

Buyer Products:

  • Oxybutynin Hydrochloride
  • Oxytrol Transdermal Patch (Oxybutynin Hydrochloride)
  
Kidney (Renal)  
Chronic Renal Failure (CRF)  
Complications  
Edema  
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium and water, but not potassium in urine.

Buyer Products:

  • Triamterene/Hydrochlorothiazide
  
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.

Buyer Products:

  • Hydrochlorothiazide
  • Microzide (Hydrochlorothiazide)
  • Metolazone
  
Nephrolithiasis/Renal Calculi (Kidney Stones)  
Calcium  
Xanthine Oxidase Inhibitors
Therapeutics that treat the formation of kidney stones from calcium deposits by reducing uric acid formation through the inhibition of xanthine oxidase.

Buyer Products:

  • Allopurinol
  
Uric Acid  
Xanthine Oxidase Inhibitors
Therapeutics that inhibit the conversion of hypoxanthine to uric acid, thus preventing the deposition of excess uric acid in the kidneys.

Buyer Products:

  • Allopurinol
  
Weight Management
Obesity  
Sympathomimetic Agents
Therapeutics that suppress appetite by stimulating the adrenergic receptors and produce adrenergic chemicals.

Buyer Products:

  • Diethylpropion HCl
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of weight disorders in very early stages of research where no human subject is involved.

Target Products:

  • MC-4 (Melanin Concentrating Hormone Antagonist)
  • Melanocortin Receptor Antagonist
  • Melanocortin Receptor Agonist
  
Wound Management  
Burns  
Complications  
Infections  
Antibacterial Agents (Antibiotics)  
Sulfonamides
Therapeutics that treat bacterial infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.

Buyer Products:

  • Silver Sulfadiazine
  
Antifungal Agents  
Sulfonamides
Therapeutics that treat fungal infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.

Buyer Products:

  • Silver Sulfadiazine
  
Medical Devices  
Drug Delivery  
Transdermal  
Patches
Medical patches applied to the skin which mediate sustained release of medications through the skin

Buyer Products:

  • Watson Laboratories, Inc.
  
Ophthalmology  
Treatment  
Dry Eye  
Lubricants
Devices used to alleviate low level of moisture in eye tissue by adding fluid.

Buyer Products:

  • Eye Irrigating Solution
  • Nature's Tears
  
Nutritional Health  
Dietary/Naturopathic Supplements  
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.

Buyer Products:

  • Watson Pharmaceuticals, Inc.
  
Outsourced Services  
Analytical Services
The Analytical Services Subsector includes outsourced services that utilize analytical instruments to analyze biological and chemical samples.

Buyer Products:

  • Amarin Development AB
  
Development/Manufacturing Services  
Chemistry Services
Outsourced companies that provide medicinal chemistry, organic synthesis, process research, cGMP synthesis, and analytical services to the biopharmaceutical industry.

Buyer Products:

  • Amarin Development AB
  
Contract Manufacturing Organizations (CMO)  
Pharmaceuticals  
Active/Intermediate Chemicals
Intermediate and active ingredient contract manufacturing organizations that produce large quantities of small molecule compounds for use in final dosage forms.

Buyer Products:

  • Sekhsaria Chemicals Ltd.
  
Final Dosage Forms
Contract Manufacturing Organizations (CMO) that produce large quantities of drug products in final dosage forms ready to be sold to end users.

Buyer Products:

  • Amarin Development AB
  
Contract Research Organizations (CRO)  
Limited Service  
Preclinical
Limited Service Contract Research Organizations that design, manage, and monitor animal studies of new therapeutics. In addition to animal studies, these limited service companies also provide formulation development services.

Buyer Products:

  • Amarin Development AB
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Pfizer Inc. n/a 179,521.061 15.19 12.28 3.53 3.54 10.09
Teva Pharmaceutical Industries Ltd (ADR) n/a 24,262.693 n/a 19.68 4.32 2.88 -38.67
Schering AG (ADR) n/a 20,873.552 25.05 25.69 2.96 n/a 5.77
King Pharmaceuticals n/a 4,396.073 44.83 12.63 2.33 2.45 4.68
Buyer
  Pfizer Inc. n/a 179,521.061 15.19 12.28 3.53 3.54 10.09
Johnson & Johnson n/a 174,197.162 16.24 15.99 3.44 3.30 6.17
Target
  Pfizer Inc. n/a 179,521.061 15.19 12.28 3.53 3.54 10.09
GlaxoSmithKline plc (ADR) n/a 165,878.661 17.69 17.38 3.93 3.96 18.50
Roche Holding Ltd. (ADR) n/a 139,217.584 30.89 23.81 5.03 4.59 7.93
sanofi-aventis (ADR) n/a 133,880.824 47.13 13.63 3.72 3.79 n/a
Merck & Co., Inc. n/a 74,838.163 15.73 14.38 3.39 3.62 4.33
Wyeth n/a 65,776.529 17.72 15.66 3.46 3.25 7.34
Abbott Laboratories n/a 63,215.948 18.80 16.88 2.86 2.88 13.96
Eli Lilly & Co. n/a 57,003.803 27.53 16.28 3.84 3.73 4.87
Bristol Myers Squibb Co. n/a 47,761.793 14.99 20.69 2.47 2.53 10.22
Teva Pharmaceutical Industries Ltd (ADR) n/a 24,262.693 n/a 19.68 4.32 2.88 -38.67
Schering AG (ADR) n/a 20,873.552 25.05 25.69 2.96 n/a 5.77
Biogen Idec Inc n/a 15,803.911 65.79 23.81 6.46 6.14 5.09
Forest Laboratories, Inc. n/a 12,768.375 18.73 16.73 4.31 4.03 n/a
Serono S.A. (ADR) n/a 10,241.916 15.98 15.03 3.86 3.69 4.86
Elan Corporation, plc (ADR) n/a 6,801.639 n/a -18.73 13.03 10.07 -10.61
King Pharmaceuticals n/a 4,396.073 44.83 12.63 2.33 2.45 4.68
Arena Pharmaceuticals, Inc. n/a 630.127 n/a -6.94 27.12 16.57 4.46
Somaxon Pharmaceuticals, Inc. n/a 344.847 n/a -7.54 n/a 3.12 3.69
Vanda Pharmaceuticals Inc. n/a 224.011 n/a n/a n/a n/a 10.43

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  West Pharmaceutical Services Inc. n/a 1,165.585 20.49 20.85 1.51 n/a n/a
Ventiv Health, Inc. n/a 816.928 18.09 22.11 1.47 1.15 -21.41
Genelabs Technologies n/a 15.323 n/a n/a 2.24 n/a 6.53
Target
  Pfizer Inc. n/a 179,521.061 15.19 12.28 3.53 3.54 10.09
Open Text Corporation (USA) n/a 713.679 393.02 15.40 1.73 1.75 8.73

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  McKesson Corporation 16.00% 14,632.871 19.31 18.30 0.17 0.16 3.73
AmerisourceBergen Corp. 13.00% 9,231.394 27.03 21.13 0.16 0.16 4.86
Walgreen Company 10.00% 40,375.218 25.19 23.91 0.91 0.87 4.27
Cardinal Health, Inc. 9.00% 27,758.866 29.94 21.57 0.35 0.35 7.37
Medicare/Medicaid/Other Government Programs n/a n/a n/a n/a n/a n/a n/a
Target
  Pfizer Inc. 90.80% 179,521.061 15.19 12.28 3.53 3.54 10.09
GlaxoSmithKline plc (ADR) 9.20% 165,878.661 17.69 17.38 3.93 3.96 18.50
Wyeth n/a 65,776.529 17.72 15.66 3.46 3.25 7.34
Eli Lilly & Co. n/a 57,003.803 27.53 16.28 3.84 3.73 4.87
Taisho Pharmaceuticals Co. Ltd. n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Bristol Myers Squibb Co. n/a 47,761.793 14.99 20.69 2.47 2.53 10.22
Elan Corporation, plc (ADR) n/a 6,801.639 n/a -18.73 13.03 10.07 -10.61
Mylan Laboratories Inc. n/a 4,388.706 26.46 17.96 3.49 3.42 5.57
Andrx Corporation n/a 1,717.570 108.54 24.80 1.71 1.53 2.27
Novadel Pharma Inc n/a 79.479 n/a n/a 89.69 n/a 25.09
Interpharm Holdings, Inc. n/a 48.695 n/a n/a 0.92 n/a 2.06
Genelabs Technologies n/a 15.323 n/a n/a 2.24 n/a 6.53
Cipla Ltd. n/a n/a n/a n/a n/a n/a n/a
Target
  Pfizer Inc. n/a 179,521.061 15.19 12.28 3.53 3.54 10.09
GlaxoSmithKline plc (ADR) n/a 165,878.661 17.69 17.38 3.93 3.96 18.50
Wyeth n/a 65,776.529 17.72 15.66 3.46 3.25 7.34
Eli Lilly & Co. n/a 57,003.803 27.53 16.28 3.84 3.73 4.87
Biosite Incorporated n/a 819.734 15.51 20.96 2.78 2.61 2.67
DOV Pharmaceutical, Inc. n/a 165.879 n/a -2.70 19.18 10.02 -8.59
Pharmacopeia Drug Discovery, Inc. n/a 78.860 n/a -7.47 3.87 3.76 2.24
Deltagen, Inc. n/a 23.311 n/a n/a 3.48 n/a 2.40
Taisho Pharmaceuticals Co. Ltd. n/a n/a n/a n/a n/a n/a n/a
Almirall Prodesfarma, S.A. n/a n/a n/a n/a n/a n/a n/a
Oregon Health Sciences University n/a n/a n/a n/a n/a n/a n/a
Memorial Sloan-Kettering Cancer Center n/a n/a n/a n/a n/a n/a n/a
University Of Michigan n/a n/a n/a n/a n/a n/a n/a
Wisconsin Alumni Research Foundation n/a n/a n/a n/a n/a n/a n/a
The Salk Institute for Biological Studies n/a n/a n/a n/a n/a n/a n/a
Mount Sinai Medical Center n/a n/a n/a n/a n/a n/a n/a
University of Virginia n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 1,652.6 102.3 1,754.9
Other Revenue 0.0 29.2 29.2
Total Revenue 1,652.6 131.5 1,784.1
Cost of Revenue 880.2 0.0 880.2
SG&A Expense 264.1 56.1 320.2
Depreciation & Amortization 164.4 0.0 164.4
Research & Development 126.3 108.8 235.0
Interest Expense 0.0 0.0 0.0
Other Operating Expense 0.0 0.0 0.0
Unusual Expense (Income) 25.1 0.0 25.1
Total Expenses 1,460.1 164.8 1,624.9
Operating Income 192.6 -33.3 159.2
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng 3.8 4.1 7.8
Gain/Loss On Sale Of Assets 3.3 0.0 3.3
Other, Net -1.0 0.0 -1.0
Income Before Taxes 198.6 -29.3 169.3
Income Taxes 73.7 0.0 73.7
Income After Taxes 124.9 -29.3 95.6
Net Income - Excl. Xord. Items 124.9 -29.3 95.6
Net Income - Incl. Xord. Items 124.9 -29.3 95.6
Income Avail. to Common 124.9 -29.3 95.6
Share Items
Basic Avg. Shares Outstanding 101.6 37.4 139.0
Basic EPS - Excl. Xord. Items 1.30 -0.78 0.69
Basic EPS - Incl. Xord. Items 1.30 -0.78 0.69
Full Dilution Adjustment 1.7 0.0 1.7
Fully Diluted Shares Outstanding 116.5 37.4 153.9
F.D. EPS - Excl. Xord. Items 1.09 -0.81 0.62
F.D. EPS - Incl. Xord. Items 1.09 -0.81 0.62
Balance Sheet
Assets
Cash and Equivalents 559.7 101.5 661.2
ST Investments 168.1 163.0 331.1
Accounts Receivable 269.8 5.9 275.7
Inventory 300.8 0.0 300.8
Prepayments and Advances 31.0 0.0 31.0
Other Current Assets 98.2 4.3 102.5
Current Assets 1,427.6 274.7 1,702.3
Accum D&A 0.0 0.0 0.0
PPE, Net 451.2 97.4 548.6
Goodwill & Intangibles 1,190.7 0.0 1,190.7
Long Term Investments 62.5 0.0 62.5
Other Assets 0.0 0.0 0.0
Other LT Assets 25.4 105.3 130.7
Total Assets 3,157.4 477.4 3,634.8
Liabilities
Accounts Payable 0.0 0.0 0.0
Payable/Accrued 209.7 16.8 226.5
ST Debt 0.0 0.0 0.0
Curr Port of LTD & Cap Lease Oblg 29.9 5.5 35.5
Other (Current) Liabilities 67.0 10.4 77.4
Current Liab. 306.6 32.8 339.4
LT Debt 573.9 0.0 573.9
Capitalized Lease Obligations 0.0 52.4 52.4
Total LT Debt 573.9 52.4 626.4
Deferred Taxes 120.7 0.0 120.7
Other LT Liab. 16.3 8.4 24.7
Total Liabilities 1,017.6 93.6 1,111.1
Shareholders Equity
Common Stock 0.4 0.0 0.4
Additional Paid in Capital 921.1 711.0 1,632.1
Retained Earnings 1,510.3 -326.0 1,184.3
Treasure Stock -300.0 0.0 -300.0
Other Equity 8.0 -1.2 6.8
Total Equity 2,139.8 383.8 2,523.6
Total Liab. & Equity 3,157.4 477.4 3,634.8
Shares Outstanding 102.0 37.7 139.7
Cash Flow
Operating Cash Flow
CF Net Income 83.7 -29.3 54.4
CF Depreciation 35.2 10.3 45.5
CF Amortization 123.3 0.0 123.3
CF Deferred Taxes -11.3 0.0 -11.3
Other Non-Cash Items 80.9 -14.1 66.8
Change in Working Capital -29.5 7.9 -21.7
Total Cash From Operating Activities 282.3 -25.2 257.1
Investing Cash Flow
Capital Expenditures -53.1 -6.4 -59.5
Other Investing Cash Flows -60.3 64.8 4.5
Total Cash From Investing Activities -113.4 58.4 -55.0
Financing Cash Flow
Dividends Paid 0.0 0.0 0.0
Purchase Or Sale of Stock -96.4 30.1 -66.3
Purchase and Retirement of Debt 0.0 -6.5 -6.5
Other Financing Cash Flow -1.5 0.1 -1.4
Total Cash From Financing Activities -97.9 23.7 -74.2
Exchange Rate Effects 0.0 0.0 0.0
Net Change in Cash 71.0 56.9 127.9
Cash Taxes Paid 112.2 0.0 112.2
Cash Interest Paid 12.4 4.5 16.9